All In Biotech

Drug Trial Radar · NCT05624268

Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD

A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant Depression

Last checked: Nov 19, 2026Latest source record: Aug 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 258 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

258

Actual

Start

Jan 24, 2023

Primary completion

May 28, 2025

Study completion Apr 15, 2026

Sponsor

Lead sponsor
COMPASS PathwaysIndustry
Sponsor type
Industry
First posted
Nov 22, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Efficacy, Safety, and Tolerability of a single administration of COMP360 in participants with treatment-resistant depression (TRD)

Conditions

  • Treatment Resistant Depression

Interventions

  • PsilocybinDrug

    COMP360 Psilocybin administered under supportive conditions

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. COMP360 25 mg versus placebo for the change from baseline in MADRS total scoreTime frame: Week 6

Locations

40 sites in 1 country. Site status is shown where the registry gives one.

  • University of Arizona College of Medicine - Tuscon

    Tuscon, Arizona

  • ProScience Research Group

    Culver City, California

  • Collaborative Neuroscience Network, LLC

    Garden Grove, California

  • Kadima Neuropsychiatry Institute

    La Jolla, California

  • University California San Diego

    La Jolla, California

  • California Center for Psychedelic Therapy

    Los Angeles, California

  • CalNeuro Research Group, Inc

    Los Angeles, California

  • Clarity Clinical Research, LLC

    Los Angeles, California

  • ATP Clinical Research, Inc.

    Orange, California

  • Artemis Institute for Clinical Research

    San Diego, California

  • Lumos Clinical Research Center

    San Jose, California

  • Stanford University

    Stanford, California

  • ASCLEPES Research Centers

    Thousand Oaks, California

  • Comprehensive Psychiatric Care

    Norwich, Connecticut

  • Clinical Neurosciecne Solutions, Inc. dba CNS Healthcare

    Orlando, Florida

  • APG Research, LLC

    Orlando, Florida

  • DMI Health Care Group, Inc

    Tampa, Florida

  • Meridien Research/Accel Research

    Tampa, Florida

  • Psych Atlanta

    Atlanta, Georgia

  • Emory University

    Atlanta, Georgia

  • Uptown Research Institute, LLC

    Chicago, Illinois

  • Sheppard Pratt Health System

    Baltimore, Maryland

  • CBH Health, LLC

    Gaithersburg, Maryland

  • Pharmasite Research, Inc

    Pikesville, Maryland

  • University of Massachusetts Medical School

    North Worcester, Massachusetts

  • University of Minnesota

    Minneapolis, Minnesota

  • University of Missouri

    Columbia, Missouri

  • Midwest Research Group

    Saint Charles, Missouri

  • Washington University School of Medicine

    St Louis, Missouri

  • Alivation Research, LLC.

    Lincoln, Nebraska

  • Bio Behavioral Health

    Toms River, New Jersey

  • New York State Psychiatric Institute

    New York, New York

  • The Medical Research Network, LLC

    New York, New York

  • Insight Clinical Trials, LLC

    Beachwood, Ohio

  • Neuro-Behaviroral Clinical Research, Inc.

    North Canton, Ohio

  • Rivus Wellness & Research Institute

    Oklahoma City, Oklahoma

  • Global Medical Institutes, LLC, Scranton Medical Institute

    Moosic, Pennsylvania

  • UT Health Science Center at Houston (UTHSC-H)

    Houston, Texas

  • Cedar Clinical Research

    Draper, Utah

  • Core Clinical Research

    Everett, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.